On November 6, the index of traditional Chinese medicine was 1,486, unchanged from the previous day, 1.65% lower than the highest point of 1,511 (2022-10-20) in the cycle, and 52.41% higher than the lowest point of 975 on November 25, 2019. (Note: the cycle refers to the period from June 30, 2019 to now)

According to the price monitoring of SunSirs, in the 44th week of 2022 (10.31-11.4), there was a total of 1 rising commodity, 3 falling commodity and 4 zero rising and falling commodities in the list of prices of traditional Chinese medicine. The main commodities that rose were: Chinese wolfberry (0.58%); The main commodities that fell were Sanchi (-1.24%), Forsythia suspensa (-1.04%) and Ophiopogon japonicus (-0.42%). The average rise and fall last week was -0.27%.

In the near future, the market supply of ophiopogon japonicus has been selling normally, and the market is stable. At present, the price of the first class unified goods in Sichuan is 85 RMB/kg, the optional goods are about 95 RMB/kg, and the charging price of the pharmaceutical factory is about 75 RMB/kg. The market supply is still acceptable.

After the price increase, since October, the market of ophiopogon japonicus has basically been running smoothly, and the supply of goods has been moving normally. The merchants of ophiopogon japonicus in the place of origin have purchased as needed, and the mentality of local commodity holders who were reluctant to sell during the previous price increase has also changed. At present, the transaction price of medium quality goods is 76-77 RMB/kg, the transaction price of good quality goods is about 80 RMB/kg, the transaction price of pharmaceutical factory feeding difference goods is about 73 RMB/kg, the transaction price of secondary goods in the origin is 72-73 RMB/kg, and the transaction price of third and fourth grade millet is about 68 RMB/kg.

At present, there is still a certain amount of inventory in the Ophiopogon japonicus production area, but the supply of goods is relatively concentrated, and some of the vendors who hold the goods have a certain degree of enthusiasm. Although the current season is getting closer and closer to the new production next year, there will also be a certain amount of demand in the pharmaceutical enterprises and the major drug markets in the future. SunSirs analysis believes that the market of Ophiopogon japonicus is difficult to change significantly in the short term.

If you have any questions, please feel free to contact SunSirs with support@sunsirs.com.